Four years after winning an FDA approval for Koselugo to treat children with the rare disorder neurofibromatosis type 1 (NF1), Ast...
Following Eli Lilly's disappointing earnings showing last week, Novo Nordisk’s latest report on the performance of its GLP-1 sta...
Allurion Technologies has presented data from two studies showing the efficacy of its swallowable gastric balloon in causing signi...
BioNTech reported surprisingly strong sales of its COVID-19 vaccine in the third quarter, which reached €1.24 billion ($1.35 b...
Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50...
Bayer has submitted a marketing authorisation application to the European Medicines Agency (EMA) for its menopause treatment elinz...
Oncolytics Biotech is seeking accelerated approval for its lead cancer therapy, pelareorep, with plans to start a registrational...
After announcing the closure of its biggest manufacturing site Sunday due to flooding caused by Hurricane Helene, Baxter Internati...
Recordati has reached an agreement with Sanofi for acquiring the worldwide rights to Enjaymo, the only approved treatment speci...